Jorge Gil-Martinez

Jorge Gil-Martinez is an accomplished biotechnology professional with extensive experience in research and development across multiple sectors, including pharmaceuticals, food and beverage, and sustainability. As the Chief Scientific Officer at Centrient Pharmaceuticals since December 2022, Jorge leads scientific initiatives to drive innovation. Previously, as VP of Global R&D at Corbion, leadership was provided to a cross-functional team to align R&D with business needs. Jorge's tenure at PepsiCo included roles as Director and Senior Manager of Global R&D, focusing on bioconversion and enzymatic technologies for food innovations. Prior to PepsiCo, significant contributions were made at Anheuser-Busch InBev in sustainability and innovation processes. Jorge also held various positions at Kerry Group, Abengoa, and has academic experience as an Assistant Professor at Universidad de Sevilla. Educational qualifications include a PhD in Biochemistry from Universidad de Sevilla, an MBA in Biotechnology, and a Master’s in Molecular Genetics and Biotechnology.